◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Overview
Price history, fund statistics and profile — an exchange-traded fund.
Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31
Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund managed by Amplify ETFs in the "Health" category. It manages roughly $5 million in assets.
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development.
Interactive chart & fund stats →
THNR Fund Statistics
| Expense ratio | 0.59% |
| Trailing yield | 1.63% |
| Assets under management | $5 million |
| Fund category | Health |
| Fund family | Amplify ETFs |
| Inception | 2024-05-20 |
The live price chart, fund profile and news are in the interactive THNR viewer.
Other Companies in Health
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.